Abilita Therapeutics

AbCellera Biologics

The company develops antibody-based medicines and discovery technologies for pharmaceutical and biotechnology partners to treat cancer, autoimmune disorders and infectious diseases.

Ablynx NV

This company develops nanobody-based therapeutic proteins to treat inflammation, haematology, oncology and pulmonary diseases for pharmaceutical partners and patients.

Protillion Biosciences

This company develops a high-throughput protein engineering platform for pharmaceutical partners to accelerate the discovery and optimisation of therapeutic antibodies and binder drugs.

Solu Therapeutics

This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.

ATB Therapeutics

The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.

AbCellera

This company develops antibody discovery technology and therapeutic medicines for biotechnology and pharmaceutical partners to treat cancer, autoimmune disorders and infectious diseases.

Abalone Bio

This company develops functional antibody drugs for pharmaceutical partners using synthetic biology and machine learning to treat challenging diseases.

ABL Bio

The company develops bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases for pharmaceutical partners and clinical research applications.